Infection and Malignancy in Rheumatic Diseases, An Issue of Rheumatic Disease Clinics of North America, 1st Edition
Author :
By Kevin Winthrop, MD, MPH and Leonard Calabrese
This issue of Rheumatic Disease Clinics will include articles such as: Vaccines and Biologics- efficacy and toxicity; Improving Vaccine administration in Practice; HCV and rheumatology; HBV reactivation and rheumatic disease; Herpes zoster in rheumat
...view more
This issue of Rheumatic Disease Clinics will include articles such as: Vaccines and Biologics- efficacy and toxicity; Improving Vaccine administration in Practice; HCV and rheumatology; HBV reactivation and rheumatic disease; Herpes zoster in rheumatic diseases; Opportunistic infections in biologic therapy, risk and prevention; and many more!
This issue of Rheumatic Disease Clinics will include articles such as: Vaccines and Biologics- efficacy and toxicity; Improving Vaccine administration in Practice; HCV and rheumatology; HBV reactivation and rheumatic disease; Herpes zoster in rheumatic diseases; Opportunistic infections in biologic therapy, risk and prevention; and many more!
Author Information
By Kevin Winthrop, MD, MPH, Associate Professor of Infectious Diseases, Ophthalmology, Professor of Public Health and Preventive Medicine, Division of Infectious Diseases, Oregon Health & Science University, Portland, Oregon and Leonard Calabrese, Professor of Medicine, Cleveland Clinic Lerner College of Medicine of CWRU
R.J. Fasermyer Chair of Clinical Immunology
By Kevin Winthrop, MD, MPH, Associate Professor of Infectious Diseases, Ophthalmology, Professor of Public Health and Preventive Medicine, Division of Infectious Diseases, Oregon Health & Science University, Portland, Oregon and Leonard Calabrese, Professor of Medicine, Cleveland Clinic Lerner College of Medicine of CWRU
R.J. Fasermyer Chair of Clinical Immunology
https://www.asia.elsevierhealth.com/infection-and-malignancy-in-rheumatic-diseases-an-issue-of-rheumatic-disease-clinics-of-north-america-9780323496759.html295125Infection and Malignancy in Rheumatic Diseases, An Issue of Rheumatic Disease Clinics of North Americahttps://www.asia.elsevierhealth.com/media/catalog/product/9/7/9780323496759_8.jpg116.09128.99USDInStock/Medicine & Surgery/Rheumatology/Clinics/Medicine/Rheumatology/Clinics/Clinics/Medicine/Rheumatology/Japan Titles43350904388725505455550546665255041525983552631601418269243350884886536505455351451205259833This issue of Rheumatic Disease Clinics will include articles such as: Vaccines and Biologics- efficacy and toxicity; Improving Vaccine administration in Practice; HCV and rheumatology; HBV reactivation and rheumatic disease; Herpes zoster in rheumatic diseases; Opportunistic infections in biologic therapy, risk and prevention; and many more! This issue of Rheumatic Disease Clinics will include articles such as: Vaccines and Biologics- efficacy and toxicity; Improving Vaccine administration in Practice; HCV and rheumatology; HBV reactivation and rheumatic disease; Herpes zoster in rheumatic diseases; Opportunistic infections in biologic therapy, risk and prevention; and many more!00add-to-cart97803234967592016ProfessionalBy Kevin Winthrop, MD, MPH and Leonard Calabrese20171Book152w x 229h (6.00" x 9.00")Elsevier0Dec 6, 2016IN STOCKBy <STRONG>Kevin Winthrop</STRONG>, MD, MPH, Associate Professor of Infectious Diseases, Ophthalmology, Professor of Public Health and Preventive Medicine, Division of Infectious Diseases, Oregon Health & Science University, Portland, Oregon and <STRONG>Leonard Calabrese</STRONG>, Professor of Medicine, Cleveland Clinic Lerner College of Medicine of CWRU
R.J. Fasermyer Chair of Clinical ImmunologyClinicsClinicsThe Clinics: Internal MedicineUnited StatesNoNoNoNoPlease SelectPlease SelectPlease Select
